Ondine Biomedical Inc. (LON:OBI – Get Free Report) traded up 13.5% on Monday . The stock traded as high as C$14.80 and last traded at C$14.75. 1,840,294 shares were traded during trading, an increase of 304% from the average session volume of 455,772 shares. The stock had previously closed at C$13.00.
Ondine Biomedical Trading Up 13.5%
The company has a quick ratio of 8.26, a current ratio of 1.23 and a debt-to-equity ratio of 11.85. The firm has a market capitalization of C$7.66 billion, a PE ratio of -2.11 and a beta of 0.32. The stock’s fifty day simple moving average is C$13.10 and its 200 day simple moving average is C$10.89.
About Ondine Biomedical
Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target.
Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.
Read More
- Five stocks we like better than Ondine Biomedical
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
